{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T05:50:08Z","timestamp":1778133008694,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aim<\/jats:title><jats:p>The objective of this study was to evaluate the reported associations between the syndrome of inappropriate antidiuretic hormone secretion (SIADH) and a variety of proton pump inhibitors (PPI) through analysis of the reports extracted from the Food and Drug Administration Adverse Event Reporting System (FAERS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>FAERS reports from January 2004 to March 2020 were used to conduct disproportionality and Bayesian analyses. The definition of SIADH relied on the preferred terms provided by the Medical Dictionary for Regulatory Activities. The time to onset, mortality, and hospitalization rates of PPI-related SIADH were also investigated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The study identified a total of 273 reports of PPI-associated SIADH, which appeared to influence more elderly than middle-aged patients (71.1% vs. 12.5%). Women were more affected than men (48.7% vs. 41.8%). Rabeprazole had a stronger SIADH association than other PPIs based on the highest reporting odds ratio (reporting odds ratio\u2009=\u200913.3, 95% confidence interval (CI)\u2009=\u20097.2, 24.9), proportional reporting ratio (proportional reporting ratio\u2009=\u200913.3, \u03c7<jats:sup>2<\/jats:sup>\u2009=\u2009113.7), and empirical Bayes geometric mean (empirical Bayes geometric mean\u2009=\u200913.3, 95% CI\u2009=\u20097.9). The median time to SIADH onset was 22 (interquartile range 6\u2013692) days after PPI administration. PPI-associated SIADH generally led to a 2.95% fatality rate and a 79.7% hospitalization rate. The highest hospitalization death rate occurred in esomeprazole (91.2%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>According to our findings, more attention should be paid to SIADH within the first several months after the administration of PPIs. For women older than 65\u2009years, dexlansoprazole may reduce the incidence of PPI-associated SIADH. Nonetheless, larger epidemiological studies are suggested to verify this conclusion.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12882-022-02818-3","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T13:03:47Z","timestamp":1652965427000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Syndrome of inappropriate antidiuretic hormone secretion is associated with different proton pump inhibitor use: a pharmacovigilance study"],"prefix":"10.1186","volume":"23","author":[{"given":"Mengmeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingjian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinghui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuanrui","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Zong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingzhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"issue":"1","key":"2818_CR1","first-page":"1","volume":"8","author":"V Dubey","year":"2018","unstructured":"Dubey V, Han M, Kopec W, Solov'yov IA, et al. K+ binding and proton redistribution in the E2P state of the H+, K+-ATPase. Sci Rep. 2018;8(1):1\u201311.","journal-title":"Sci Rep"},{"issue":"9","key":"2818_CR2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/2042098617715381","volume":"8","author":"ML Maes","year":"2017","unstructured":"Maes ML, Fixen DR, Linnebur SA. Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence. Ther Adv Drug Saf. 2017;8(9):273\u201397.","journal-title":"Ther Adv Drug Saf"},{"issue":"6","key":"2818_CR3","doi-asserted-by":"publisher","first-page":"322","DOI":"10.4166\/kjg.2020.75.6.322","volume":"75","author":"JS Kim","year":"2020","unstructured":"Kim JS, Kim BW, Kim DH, et al. Guidelines for non-variceal upper gastrointestinal bleeding. Korean J Gastroenterol. 2020;75(6):322\u201332.","journal-title":"Korean J Gastroenterol"},{"key":"2818_CR4","doi-asserted-by":"publisher","first-page":"l536","DOI":"10.1136\/bmj.l536","volume":"364","author":"AJ Stanley","year":"2019","unstructured":"Stanley AJ, Laine L. Management of acute upper gastrointestinal bleeding. BMJ. 2019;364:l536.","journal-title":"BMJ."},{"key":"2818_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1756284818777943","volume":"11","author":"OO Halfdanarson","year":"2018","unstructured":"Halfdanarson OO, Pottegard A, Bjornsson ES, et al. Proton-pump inhibitors among adults: a nationwide drug-utilization study. Ther Adv Gastroenterol. 2018;11:1\u201311.","journal-title":"Ther Adv Gastroenterol"},{"issue":"5","key":"2818_CR6","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1177\/1756283X16650156","volume":"9","author":"A Pottegard","year":"2016","unstructured":"Pottegard A, Broe A, Hallas J, de Muckadell OB, Lassen AT, Lodrup AB. Use of proton-pump inhibitors among adults: a Danish nationwide drug utilization study. Ther Adv Gastroenterol. 2016;9(5):671\u20138.","journal-title":"Ther Adv Gastroenterol"},{"issue":"3","key":"2818_CR7","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/apt.15834","volume":"52","author":"J Yuan","year":"2020","unstructured":"Yuan J, Zhang C, Sparks JA, et al. Regular use of proton pump inhibitor and risk of rheumatoid arthritis in women: a prospective cohort study. Aliment Pharmacol Ther. 2020;52(3):449\u201358.","journal-title":"Aliment Pharmacol Ther"},{"issue":"20","key":"2818_CR8","doi-asserted-by":"publisher","first-page":"5203","DOI":"10.3390\/ijms20205203","volume":"20","author":"R Fossmark","year":"2019","unstructured":"Fossmark R, Martinsen TC, Waldum HL. Adverse effects of proton pump inhibitors-evidence and plausibility. Int J Mol Sci. 2019;20(20):5203.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2818_CR9","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/lio2.187","volume":"3","author":"S Brisebois","year":"2018","unstructured":"Brisebois S, Merati A, Giliberto JP. Proton pump inhibitors: review of reported risks and controversies. Laryngoscope Investig Otolaryngol. 2018;3(6):457\u201362.","journal-title":"Laryngoscope Investig Otolaryngol"},{"issue":"5","key":"2818_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000487154","volume":"25","author":"S Xavier","year":"2018","unstructured":"Xavier S, Magalhaes J, Cotter J. Proton pump inhibitors: are they a real threat to the patient? GE Port J Gastroenterol. 2018;25(5):243\u201352.","journal-title":"GE Port J Gastroenterol"},{"key":"2818_CR11","doi-asserted-by":"publisher","unstructured":"Aratani S, Matsunobu T, Kawai T, et al. Syndrome of inappropriate secretion of antidiuretic hormone caused by very short-term use of proton pump inhibitor. Keio J Med. 2020. https:\/\/doi.org\/10.2302\/kjm.2020-0008-CR.","DOI":"10.2302\/kjm.2020-0008-CR"},{"issue":"1","key":"2818_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13256-020-02423-8","volume":"14","author":"IJB van der Zalm","year":"2020","unstructured":"van der Zalm IJB, Tobe TJM, Logtenberg SJJ. Omeprazole-induced and pantoprazole-induced asymptomatic hyponatremia: a case report. J Med Case Rep. 2020;14(1):83.","journal-title":"J Med Case Rep"},{"issue":"2","key":"2818_CR13","first-page":"000341","volume":"3","author":"F Ferreira","year":"2016","unstructured":"Ferreira F, Mateus S, Santos AR, Moreira H, Ferreira NR. Pantoprazole-related symptomatic hyponatremia. Eur J Case Rep Intern Med. 2016;3(2):000341.","journal-title":"Eur J Case Rep Intern Med"},{"issue":"1","key":"2818_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/pds.668","volume":"11","author":"EP van Puijenbroek","year":"2002","unstructured":"van Puijenbroek EP, Bate A, Leufkens HG, Lindquist M, Orre R, Egberts AC. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf. 2002;11(1):3\u201310.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"2818_CR15","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00787-010-0087-7","volume":"19","author":"M Szumilas","year":"2010","unstructured":"Szumilas M. Explaining odds ratios. J Can Acad Child Adolesc Psychiatry. 2010;19(3):227\u20139.","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"issue":"11","key":"2818_CR16","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1002\/pds.2014","volume":"19","author":"N Ooba","year":"2010","unstructured":"Ooba N, Kubota K. Selected control events and reporting odds ratio in signal detection methodology. Pharmacoepidemiol Drug Saf. 2010;19(11):1159\u201365.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"2818_CR17","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pds.677","volume":"10","author":"SJ Evans","year":"2001","unstructured":"Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 2001;10(6):483\u20136.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"2818_CR18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2165\/00002018-200225060-00002","volume":"25","author":"A Bate","year":"2002","unstructured":"Bate A, Lindquist M, Edwards IR, Orre R. A data mining approach for signal detection and analysis. Drug Saf. 2002;25(6):393\u20137.","journal-title":"Drug Saf"},{"issue":"5","key":"2818_CR19","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1517\/14740338.4.5.929","volume":"4","author":"M Hauben","year":"2005","unstructured":"Hauben M, Madigan D, Gerrits CM, Walsh L, Van Puijenbroek EP. The role of data mining in pharmacovigilance. Expert Opin Drug Saf. 2005;4(5):929\u201348.","journal-title":"Expert Opin Drug Saf"},{"issue":"21","key":"2818_CR20","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.1002\/sim.2473","volume":"25","author":"GN Noren","year":"2006","unstructured":"Noren GN, Bate A, Orre R, Edwards IR. Extending the methods used to screen the WHO drug safety database towards analysis of complex associations and improved accuracy for rare events. Stat Med. 2006;25(21):3740\u201357.","journal-title":"Stat Med"},{"issue":"7\u20138","key":"2818_CR21","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1345\/aph.1C515","volume":"37","author":"M Hauben","year":"2003","unstructured":"Hauben M. A brief primer on automated signal detection. Ann Pharmacother. 2003;37(7\u20138):1117\u201323.","journal-title":"Ann Pharmacother"},{"issue":"6","key":"2818_CR22","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2165\/00002018-200225060-00001","volume":"25","author":"A Szarfman","year":"2002","unstructured":"Szarfman A, Machado SG, O'Neill RT. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database. Drug Saf. 2002;25(6):381\u201392.","journal-title":"Drug Saf"},{"issue":"3","key":"2818_CR23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/00031305.1999.10474456","volume":"53","author":"W DuMouchel","year":"1999","unstructured":"DuMouchel W. Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. Am Stat. 1999;53(3):177\u201390.","journal-title":"Am Stat"},{"issue":"628","key":"2818_CR24","first-page":"2116","volume":"14","author":"J Martin","year":"2018","unstructured":"Martin J, Burnier M, Lu H. Approach to the syndrome of inappropriate antidiuretic hormone secretion (SIADH). Rev Med Suisse. 2018;14(628):2116\u201320.","journal-title":"Rev Med Suisse"},{"key":"2818_CR25","volume-title":"Syndrome of Inappropriate Antidiuretic Hormone Secretion","author":"M Yasir","year":"2020","unstructured":"Yasir M, Mechanic OJ. Syndrome of Inappropriate Antidiuretic Hormone Secretion.2020; Cited 14 Apr 2020. Available from URL: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK507777\/"},{"issue":"10 Suppl 1","key":"2818_CR26","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.amjmed.2013.07.006","volume":"126","author":"JG Verbalis","year":"2013","unstructured":"Verbalis JG, Goldsmith SR, Greenberg A, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013;126(10 Suppl 1):S1\u201342.","journal-title":"Am J Med"},{"key":"2818_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejim.2018.08.012","volume":"59","author":"H Falhammar","year":"2019","unstructured":"Falhammar H, Lindh JD, Calissendorff J, Skov J, Nathanson D, Mannheimer B. Associations of proton pump inhibitors and hospitalization due to hyponatremia: a population-based case-control study. Eur J Intern Med. 2019;59:65\u20139.","journal-title":"Eur J Intern Med"},{"issue":"1","key":"2818_CR28","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1053\/j.ajkd.2008.03.004","volume":"52","author":"G Liamis","year":"2008","unstructured":"Liamis G, Milionis H, Elisaf M. A review of drug-induced hyponatremia. Am J Kidney Dis. 2008;52(1):144\u201353.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"2818_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5414\/CNP68065","volume":"68","author":"UC Brewster","year":"2007","unstructured":"Brewster UC, Perazella MA. Proton pump inhibitors and the kidney: critical review. Clin Nephrol. 2007;68(2):65\u201372.","journal-title":"Clin Nephrol"},{"issue":"4","key":"2818_CR30","first-page":"542","volume":"81","author":"A Engelen","year":"2018","unstructured":"Engelen A, Christiaens P, Bossuyt P, et al. Syndrome of inappropriate antidiuretic hormone secretion caused by proton pump inhibitor use. Acta Gastroenterol Belg. 2018;81(4):542.","journal-title":"Acta Gastroenterol Belg"},{"issue":"10","key":"2818_CR31","doi-asserted-by":"publisher","first-page":"dgaa194","DOI":"10.1210\/clinem\/dgaa194","volume":"105","author":"H Falhammar","year":"2020","unstructured":"Falhammar H, Skov J, Calissendorff J, et al. Associations between antihypertensive medications and severe hyponatremia: a Swedish population-based case-control study. J Clin Endocrinol Metab. 2020;105(10):dgaa194.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2818_CR32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.beem.2016.02.009","volume":"30","author":"M Cuesta","year":"2016","unstructured":"Cuesta M, Thompson CJ. The syndrome of inappropriate antidiuresis (SIAD). Best Pract Res Clin Endocrinol Metab. 2016;30(2):175\u201387.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"7","key":"2818_CR33","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/pds.2153","volume":"20","author":"KJ Lin","year":"2011","unstructured":"Lin KJ, Garcia Rodriguez LA, Hernandez-Diaz S. Systematic review of peptic ulcer disease incidence rates: do studies without validation provide reliable estimates? Pharmacoepidemiol Drug Saf. 2011;20(7):718\u201328.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"46","key":"2818_CR34","doi-asserted-by":"publisher","first-page":"17568","DOI":"10.3748\/wjg.v20.i46.17568","volume":"20","author":"S Quan","year":"2014","unstructured":"Quan S, Frolkis A, Milne K, et al. Upper-gastrointestinal bleeding secondary to peptic ulcer disease: incidence and outcomes. World J Gastroenterol. 2014;20(46):17568\u201377.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"2818_CR35","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1097\/01.mcg.0000225658.30803.79","volume":"41","author":"TS Chen","year":"2007","unstructured":"Chen TS, Chang FY. The prevalence and risk factors of reflux esophagitis among adult Chinese population in Taiwan. J Clin Gastroenterol. 2007;41(9):819\u201322.","journal-title":"J Clin Gastroenterol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02818-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-022-02818-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02818-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T14:43:21Z","timestamp":1727275401000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-022-02818-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,19]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2818"],"URL":"https:\/\/doi.org\/10.1186\/s12882-022-02818-3","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,19]]},"assertion":[{"value":"11 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We collected data used the Food and Drug Administration Adverse Event Reporting System, and all methods were performed in accordance with the declaration of Helsinki..","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"191"}}